what is the most performance mid cap stock between april 2 2024 and april 30 2024

GeneDx (WGS) had the highest return between April 2, 2024 and April 30, 2024 by a mid-cap US stock, returning 89.7%.

ASSET DATE % RETURN
GeneDx (WGS)
4/2/2024 - 4/30/2024
89.67%
Loar (LOAR)
4/2/2024 - 4/30/2024
86.86%
Immunitybio (IBRX)
4/2/2024 - 4/30/2024
53.07%
Semtech (SMTC)
4/2/2024 - 4/30/2024
32.19%
TransMedics (TMDX)
4/2/2024 - 4/30/2024
30.55%
Grupo Financiero Galicia SA ADR (GGAL)
4/2/2024 - 4/30/2024
27.93%
Impinj (PI)
4/2/2024 - 4/30/2024
26.49%
Regencell Bioscience (RGC)
4/2/2024 - 4/30/2024
25.75%
BW LPG (BWLP)
4/2/2024 - 4/30/2024
25.47%
Oscar Health (OSCR)
4/2/2024 - 4/30/2024
24.34%
Victory Capital (VCTR)
4/2/2024 - 4/30/2024
23.03%
Dave (DAVE)
4/2/2024 - 4/30/2024
22.93%
Argan (AGX)
4/2/2024 - 4/30/2024
21.14%
Revolution Medicines (RVMD)
4/2/2024 - 4/30/2024
20.34%
Hudbay Minerals (HBM)
4/2/2024 - 4/30/2024
19.6%
Turkcell Iletisim Hizmetleri AS (TKC)
4/2/2024 - 4/30/2024
19.38%
Alvotech (ALVO)
4/2/2024 - 4/30/2024
18.95%
Iridium Communications (IRDM)
4/2/2024 - 4/30/2024
18.83%
GDS (GDS)
4/2/2024 - 4/30/2024
18.43%
Fortuna Silver Mines (FSM)
4/2/2024 - 4/30/2024
17.92%
Inspire Medical Systems (INSP)
4/2/2024 - 4/30/2024
17.85%
AAR (AIR)
4/2/2024 - 4/30/2024
17.81%
Allegheny Technologies (ATI)
4/2/2024 - 4/30/2024
17.61%
Manchester United (MANU)
4/2/2024 - 4/30/2024
17.48%
Nextdecade (NEXT)
4/2/2024 - 4/30/2024
16.94%
Mid-cap stocks are treated as having a market cap between $2B and $10B.